COVID-19 and Cardiovascular Disease: From Bench to Bedside.

Authors:
Chung MK; Zidar DA; Bristow MR; Cameron SJ; Chan T and 8 more

Journal:
Circ Res

Publication Year: 2021

DOI:
10.1161/CIRCRESAHA.121.317997

PMCID:
PMC8048382

PMID:
33856918

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Circ Res

Abbreviation: Circ Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Vascular Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Directional Endothelial Communication by Polarized Extracellular Vesicle Release.
Raju S; Botts SR; Blaser MC and 16 more (2024) - Transparency Score: 4/6
Reversal of Pulmonary Hypertension in a Human-Like Model: Therapeutic Targeting of Endothelial DHFR.
Murugesan P; Zhang Y; Huang Y and 6 more (2024) - Transparency Score: 3/6
Sox9 Accelerates Vascular Aging by Regulating Extracellular Matrix Composition and Stiffness.
Faleeva M; Ahmad S; Theofilatos K and 7 more (2024) - Transparency Score: 4/6
Cardiac Alternans: From Bedside to Bench and Back.
Qu Z; Weiss JN. (2023) - Transparency Score: 3/6
Cardiovascular Calcification Heterogeneity in Chronic Kidney Disease.
Hutcheson JD; Goettsch C. (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosures J. Loscalzo is scientific co-founder of Scipher Medicine, Inc, a company that focuses on utilizing network medicine approaches to understanding disease mechanisms and identifying therapeutic targets. The other authors report no conflicts."

Evidence found in paper:

"Sources of Funding M.K. Chung received funding from 810959 AHA Covid-19 Rapid Response Research Coordinating Center grant, 814633 AHA Covid-19 Rapid Response Research grant, NIH/NHLBI R01HL111314. D.A. Zidar received funding from Veterans Affairs COVID-19 Rapid Response Pilot and HIH/NCI UO1CA260513-01. J. Loscalzo received funding from NIH/NHLBI R01HL155107, NIH/NHLBI R01HL55096, NIH/NHLBI U54 HL119145, NIH/NIGMS U01 HG007690, and AHA grant D700382. N.R. Tucker received funding from K01-HL140187. S.J. Cameron received funding from grants NHLBI K08HL128856 and LRPHL120200."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025